Company Announcements

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Apr. 2, 2024-- Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities Health Care Conference on Tuesday, May 14^th, at the Encore Hotel, Las Vegas, Nevada. John Reed, Executive Vice President, Innovative Medicine, R&D, will represent the Company in a session scheduled at 4:40 pm (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240402572248/en/

Media contact:
media-relations@its.jnj.com

Investor contact:
investor-relations@its.jnj.com

Source: Johnson & Johnson